• Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Rating of "Moderate Buy" from Analysts

    ソース: Buzz FX / 23 12 2024 03:21:12   America/New_York


    Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Rating of "Moderate Buy" from Analysts Written by MarketBeat December 23, 2024 Share Link copied to clipboard. Sutro Biopharma, Inc. ( NASDAQ:STRO - Get Free Report ) has been given an av
    Read more...
シェアする